| (INR) | Jun 2017 | Y/Y change |
|---|---|---|
| Revenue | 169.94M | — |
| Operating expense | — | — |
| Net income | -28.79M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, JENBURPH.BO returned -9.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -5.1% |
| 1 year | -9.0% |
| 5 years | +127.6% |
| 10 years | +248.6% |
| All-time high | ₹1,372.10 (Jun 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ₹1,000 in JENBURPH.BO would be worth today ›No. Jenburkt Pharmaceuticals Limited has not paid a dividend in the past 12 months.
Jenburkt Pharmaceuticals Limited is part of the Healthcare sector.
Jenburkt Pharmaceuticals Limited has a market cap of 4.58B INR, based on the latest quote.
